Notebook

Panels Under The Axe Human-Embryo Research Opposition Telemedicine Delivers A Diagnosis Symposia Mark Pasteur's Passing Microbiologists Stake Home Page Dr. Seuss, Capitalist Tool Funding Novice Biomedical Faculty Math Medalists The AIDS Research Evaluation Working Group and six Area Review Panels currently charged with evaluating all National Institutes of Health-sponsored AIDS research (B. Goodman, The Scientist, July 10, 1995, page 1) find themselves facing a challenge they may not be abl

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The AIDS Research Evaluation Working Group and six Area Review Panels currently charged with evaluating all National Institutes of Health-sponsored AIDS research (B. Goodman, The Scientist, July 10, 1995, page 1) find themselves facing a challenge they may not be able to overcome. Last month, the House Appropriations Committee voted to eliminate the direct appropriation of the AIDS budget to NIH through the Office of AIDS Research (OAR), under whose auspices the panels are working. In the plan proposed by the subcommittee, monies will be given directly to the 24 NIH institutes and will not be designated specifically for AIDS research. "That endangers the whole [panel] review," says AIDS activist Gregg Gonsalves of the New York-based Treatment Action Group, a member of the etiology and pathogenesis panel. "If OAR doesn't get a single budget line, how significant will the recommendations be? I've never seen such a huge, huge battle around ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies